Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation, Management Issues.

Description: Valeant Pharmaceuticals said on Monday that it was willing to raise its offer for the Botox maker Allergan, and once again invited the company to negotiate a friendly deal.

Source: NYTimes.com

Date: Oct 27, 2014

Link: http://dealbook.nytimes.com/2014/10/27/valeant-ready-to-raise-offer-for-botox-maker-allergan/?_php=true&_type=blogs&_r=0

Questions for Discussions:

  • What will the affect of a $200 offer be on both firms’ stock values?
  • Do you think the strategy of publically offering this price is a correct one?

Leave a Reply

Your email address will not be published.